#ADA26: 19% of Phase 3 patients quit Boehringer obesity shot over side effectsnews2026-06-07T18:30:38+00:00June 7th, 2026|Endpoints News|
#ADA26: Pfizer monthly shot shows effect on obesity, diabetesnews2026-06-06T13:00:02+00:00June 6th, 2026|Endpoints News|
#ADA26: Roche to start Phase 2 petrelintide, enicepatide combo trial this yearnews2026-06-06T10:44:27+00:00June 6th, 2026|Endpoints News|
Lawmakers propose China restrictions; #ASCO26 recap; and morenews2026-06-06T10:00:31+00:00June 6th, 2026|Endpoints News|
#ADA26: Roche incretin shot works in mid-stage trial in type 1 diabetesnews2026-06-05T22:30:23+00:00June 5th, 2026|Endpoints News|
NYMEX: US gas futures scale back weather-driven gainsnews2026-06-05T21:14:00+00:00June 5th, 2026|Independent Commodity Intelligence Services (ICIS)|
Asia-US container rates soar on demand surge as volumes pulled forward to beat tariffsnews2026-06-05T21:05:00+00:00June 5th, 2026|Independent Commodity Intelligence Services (ICIS)|
